ExsoMed Corporation, an Aliso Viejo, Calif.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, completed its second round of financing of undisclosed amount.
This round, comprised entirely of private investors, included participation from both existing investors and new individuals.
Proceeds from the financing will be used to further drive ExsoMed’s core business, expand the company’s commitment to surgeon education, and accelerate upcoming product launches scheduled for Q4 2020 and early 2021.
Led by Daniel Mickelsen, Chief Operating and Financial Officer, ExsoMed is a medical device company providing orthopaedic surgeons with innovative solutions in hand surgery. This financing builds on a year characterized by a rapidly growing surgeon user base, significant adoption of the company’s flagship product INnate™ as a standard for minimally invasive fixation of metacarpal fractures, and increasing market momentum in the hand surgery space.